comparemela.com

Latest Breaking News On - Inducement award program - Page 1 : comparemela.com

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

/PRNewswire/ Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney.

United kingdomUnited statesAkebia therapeutics incAkebia inducement award programAkebia therapeuticsNasdaq listing ruleInducement award program

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

/PRNewswire/ Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney.

United kingdomUnited statesAkebia therapeutics incAkebia inducement award programAkebia therapeuticsNasdaq listing ruleInducement award program

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CAMBRIDGE, Mass., Dec. 1, 2021 /PRNewswire/ Akebia Therapeutics, Inc. , a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, granted 21. | December 1, 2021

United kingdomUnited statesMercedes carrascoAkebia therapeutics incPrnewswire akebia therapeutics incAkebia inducement award programNasdaq listing ruleInducement award programAkebia therapeuticsNc stock exchangePress releaseRanted akba us00972d1054

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

/PRNewswire/ Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney.

United kingdomUnited statesMercedes carrascoAkebia therapeutics incPrnewswire akebia therapeutics incAkebia inducement award programNasdaq listing ruleInducement award programAkebia therapeutics

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

/PRNewswire/ Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney.

United kingdomUnited statesMercedes carrascoAkebia therapeutics incPrnewswire akebia therapeutics incAkebia inducement award programNasdaq listing ruleInducement award programAkebia therapeutics

vimarsana © 2020. All Rights Reserved.